Back to Search
Start Over
Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial
- Source :
- Nature Communications, Vol 14, Iss 1, Pp 1-15 (2023)
- Publication Year :
- 2023
- Publisher :
- Nature Portfolio, 2023.
-
Abstract
- Authors have previously reported on the efficacy and safety of the recombinant spike protein nanoparticle vaccine, NVX-CoV2373, in healthy adults. In this work, they assess anti-spike binding IgG, anti-RBD binding IgG and neutralising antibody titer as correlates of risk and protection against COVID-19.
- Subjects :
- Science
Subjects
Details
- Language :
- English
- ISSN :
- 20411723
- Volume :
- 14
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Nature Communications
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.f3590fa9e20145b28dc93b73d492a237
- Document Type :
- article
- Full Text :
- https://doi.org/10.1038/s41467-022-35768-3